Government cannot mandate HIV drug coverage, rules Texas judge
U.S. District Judge Reed O'Connor has ruled that the Affordable Care Act's mandate for free coverage of HIV prevention drugs violates the religious freedom of a Christian-owned company, Bloomberg reports.
Braidwood Management Inc. had challenged the provision requiring it to cover Truvada and Descovy, a pair of widely-used pre-exposure prophylactic drugs more commonly known as PrEP. Thousands of Americans — especially gay and bisexual men — take PrEP daily as a preventative measure against HIV.
In their initial complaint, the plaintiffs argued that the ACA mandate "forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use." O'Connor ultimately sided with the plaintiffs, claiming the defendants did not show a "compelling interest in forcing private, religious corporations to cover PrEP drugs with no cost-sharing and no religious exemptions."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The suit was led by attorney Jonathan Mitchell, the former Republican solicitor general of Texas who is known for his efforts to restrict abortion access in the state. Mitchell argues that the entire preventive services mandate under the ACA is invalid because those who manage the list are too empowered to not have Senate confirmation, Bloomberg writes.
At this time, it's unclear whether O'Connor's ruling will be nationally endorsed; still, it could have a major impact on access to preventative care and important free health services for Americans. "It's a disappointing decision because it has broader implications for harm for folks that are just trying to work and live and access health care," attorney Shelley Skeen told NBC News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
A growing iodine deficiency could bring back America's goiter
Under the Radar Ailment is back thanks to complacency, changing diets and a lack of public-health education
By Harriet Marsden, The Week UK Published
-
Cannabinoid hyperemesis syndrome: a rare but troubling health risk for cannabis users
The Explainer The illness is sending some chronic marijuana users to emergency care for painful persistent vomiting
By Theara Coleman, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
Pink cocaine: the new drug cocktail responsible for an increasing number of deaths
In the Spotlight The substance has been linked to the death of Liam Payne and named in a lawsuit against Sean 'Diddy' Combs
By Justin Klawans, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Flame retardants found in black plastics could have health consequences
Under the Radar Time to replace your kitchen tools
By Devika Rao, The Week US Published
-
Preeclampsia: The dangerous pregnancy condition is affecting more women
Under the Radar The condition of preeclampsia is on the rise and can be deadly if left untreated
By Devika Rao, The Week US Published
-
The EEE virus is spreading in the US
The Explainer The mosquito strikes again
By Devika Rao, The Week US Published